Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $114.37 million. The enterprise value is $79.09 million.

Market Cap	114.37M
Enterprise Value	79.09M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

CGTX has 89.35 million shares outstanding. The number of shares has increased by 83.15% in one year.

Current Share Class	89.35M
Shares Outstanding	89.35M
Shares Change (YoY)	+83.15%
Shares Change (QoQ)	+13.66%
Owned by Insiders (%)	1.17%
Owned by Institutions (%)	17.33%
Float	82.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.32
P/TBV Ratio	3.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.02.

Current Ratio	3.45
Quick Ratio	3.36
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,676.85

Financial Efficiency

Return on equity (ROE) is -88.60% and return on invested capital (ROIC) is -109.69%.

Return on Equity (ROE)	-88.60%
Return on Assets (ROA)	-75.99%
Return on Invested Capital (ROIC)	-109.69%
Return on Capital Employed (ROCE)	-138.68%
Weighted Average Cost of Capital (WACC)	11.86%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +192.37% in the last 52 weeks. The beta is 1.39, so CGTX's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+192.37%
50-Day Moving Average	1.05
200-Day Moving Average	1.39
Relative Strength Index (RSI)	63.82
Average Volume (20 Days)	1,281,012

Short Selling Information

The latest short interest is 7.32 million, so 8.19% of the outstanding shares have been sold short.

Short Interest	7.32M
Short Previous Month	6.85M
Short % of Shares Out	8.19%
Short % of Float	8.89%
Short Ratio (days to cover)	4.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.80M
Pretax Income	-23.49M
Net Income	-23.49M
EBITDA	-47.76M
EBIT	-47.80M
Earnings Per Share (EPS)	-$0.32

Full Income Statement

Balance Sheet

The company has $36.81 million in cash and $638,000 in debt, giving a net cash position of $36.17 million or $0.40 per share.

Cash & Cash Equivalents	36.81M
Total Debt	638,000
Net Cash	36.17M
Net Cash Per Share	$0.40
Equity (Book Value)	34.27M
Book Value Per Share	0.39
Working Capital	34.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-24.59M
Capital Expenditures	n/a
Depreciation & Amortization	36,000
Net Borrowing	-353,000
Free Cash Flow	-24.59M
FCF Per Share	-$0.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-83.15%
Shareholder Yield	-83.15%
Earnings Yield	-20.38%
FCF Yield	-21.33%

Analyst Forecast

The average price target for CGTX is $3.33, which is 160.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.33
Price Target Difference	160.16%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1